Social Pulse: Endocyte Inc (ECYT.OQ)
ECYT.OQ on NASDAQ Stock Exchange Global Select Market
18.80USD
1 Aug 2013
18.80USD
1 Aug 2013
Price Change (% chg)
$0.83 (+4.62%)
$0.83 (+4.62%)
Prev Close
$17.97
$17.97
Open
$18.12
$18.12
Day's High
$18.86
$18.86
Day's Low
$18.03
$18.03
Volume
94,419
94,419
Avg. Vol
77,789
77,789
52-wk High
$18.86
$18.86
52-wk Low
$7.50
$7.50
- Meet High Risk And High Reward, Biotech's Profit Partners: Bert Hazlett
- Merck Needs Acquisitions: Here's The List
- Five Keys To Making A Cancer Smart Bomb Go 'BOOM!'
- A Valuation Model For Endocyte's Small Molecule Drug Conjugates And Imaging Platform
- 3 Biotech Stocks Spiking on Big Volume
- Why Endocyte's Small Molecule Drug Conjugates + Imaging Platform Is Undervalued
Press Releases
- Merck and Endocyte Announce Acceptance for Review of European Marketing Authorization Applications for Vintafolide and Companion Diagnostic Etarfolatide for Folate-Receptor Positive Platinum-Resistant Ovarian Cancer
- Endocyte to Present at Upcoming Healthcare Conferences
- Endocyte Reports Third Quarter 2012 Financial Results and Business Update
- Endocyte Announces Third Quarter 2012 Earnings Conference Call
- Data Published Identify the Folate Receptor as a Potential Biomarker for Targeted Therapies in a Majority of Lung Cancers

